Sands, B.
Infliximab maintenance therapy for fistualising Crohn's disease - 876-885
Journal print article
Patients with fistualising Crohn's disease have an increased likelihood of a continued response over a 54 week period if infliximab treatment is continued every 8 weeks. 3 tabs 2 figs. = New England Journal of Medicine
Crohn's disease
Infliximab maintenance therapy for fistualising Crohn's disease - 876-885
Journal print article
Patients with fistualising Crohn's disease have an increased likelihood of a continued response over a 54 week period if infliximab treatment is continued every 8 weeks. 3 tabs 2 figs. = New England Journal of Medicine
Crohn's disease